Literatur:
Marventano S, Salomone F, Godos J et al. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Clin Nutr. 2016;35:1269-81
Powell EE, Wong V, Rinella M et al. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212-24
Wang H, Guan W, Yang W et al. Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK signal pathway. PLoS One. 2014;9:e92482
Hsu SJ, Lee FY, Wang SS et al. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats. Hepatology. 2015;61:1672-84
Brandt A, Nier A, Jin CJ et al. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function. Redox Biol. 2019;21:101092
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müssig, K. Fettleber: Wirkt Kaffee tatsächlich protektiv?. Info Diabetol 17, 30–31 (2023). https://doi.org/10.1007/s15034-023-4507-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15034-023-4507-4